2014 Annual Meeting | 7HC.009 - Symptomatic Management in Multiple Sclerosis

Date Friday 05/02/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Bruce A. Cree, MD, PhD, MAS, FAAN

Topic(s)

Learning Objectives Participants should become familiar with the current best practice management for the following MS symptoms: spasticity and locomotion, sleep and fatigue, pain, depression, and cognitive dysfunction, and bowel, bladder, and sexual dysfunction.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:50 PM		Locomotion and Spasticity Andrew D. Goodman, MD, FAAN
01:50 PM - 01:55 PM		Questions and Answers
01:55 PM - 02:45 PM		Fatigue and Sleep Disorders Timothy W. West, MD
02:45 PM - 02:50 PM		Questions and Answers
02:50 PM - 03:10 PM		Break
03:10 PM - 04:00 PM		Pain, Depression, and Cognitive Dysfunction Bruce A. Cree, MD, PhD, MAS, FAAN
04:00 PM - 04:05 PM		Questions and Answers
04:05 PM - 04:55 PM		Bowel, Bladder, and Sexual Dysfunction Elizabeth Crabtree-Hartman, MD
04:55 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Andrew D. Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Elizabeth Crabtree-Hartman, MD	Dr. Crabtree-Hartman has nothing to disclose.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Timothy W. West, MD	Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. West has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.

��ɫ��

��ɫ��